Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016330	du-k	— (—)	625	804	100.00%	Distribution not available
3016330	du-k	mmol/24h (mmol/24h)	19	19	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Endocrine, nutritional and metabolic diseases

143

158

4.61

46.80

1.4

1.2

87.09

77.51

mmol/24h

—

Disorders resulting from impaired renal tubular function

18.25

22.12

1.3

1.4

—

General symptoms and signs

165

355

2.33

19.40

1.3

96.98

71.27

mmol/24h

—

Headache

319

2.60

16.82

1.2

1.3

—

71.27

—

Other CVD (FINNGEN)

23.71

16.14

1.3

1.8

—

Cardiac arrhythmias

244

2.60

15.48

1.3

1.2

89.39

80.18

mmol/24h

—

Type 2 diabetes, wide definition

111

305

2.37

14.79

1.3

1.2

—

82.92

—

Abnormalities of heart beat

157

3.35

14.75

1.4

1.2

—

95.07

—

Other heart diseases, wide

135

388

2.16

14.31

1.3

87.49

77.63

mmol/24h

—

Migraine

224

2.78

14.23

1.3

—

75.27

—

Calculus of kidney and ureter

144

3.41

14.06

1.4

1.3

—

92.87

—

Urolithiasis

160

3.26

13.88

1.4

1.3

—

92.87

—

Other antidepressants

145

359

2.11

13.85

1.3

84.80

79.49

mmol/24h

—

Hypotension

5.43

13.51

1.3

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

233

2.46

12.98

1.3

1.2

—

84.93

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

129

413

2.06

12.44

1.3

96.30

70.86

mmol/24h

—

Other and unspecified myopathies

8.46

12.37

1.2

—

Hypothyroidism, strict autoimmune

101

296

2.26

12.21

1.3

85.91

71.25

mmol/24h

—

Disorders of the thyroid gland

130

418

2.03

12.07

1.3

92.06

71.21

mmol/24h

—

Renal failure

171

2.89

11.60

1.3

—

79.26

—

Obesity related asthma

184

2.89

11.59

1.3

1.2

—

86.29

—

Hypothyroidism, other/unspecified

122

397

2.03

11.32

1.3

96.30

71.21

mmol/24h

—

Use of pramipexole

3.75

11.26

1.2

1.3

—

89.82

—

Renal tubulo-interstitial diseases

114

427

2.05

11.21

1.3

—

78.77

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

120

3.26

10.50

1.4

1.2

—

90.68

—

Fever of other and unknown origin

254

2.37

9.57

1.3

—

77.74

—

Adverse effects, not elsewhere classified

3.41

9.29

1.2

1.3

—

97.62

—

Intestinal infectious diseases

119

493

1.88

9.29

1.4

1.3

—

80.34

—

Asthma, excluding more controls

105

278

2.01

9.16

1.3

—

85.30

—

Exposure to unspecified factor

123

516

1.85

9.15

1.2

1.3

—

78.89

—

Diarrhoea and gastroenteritis of presumed infectious origin

407

2.01

8.81

1.4

1.3

—

81.35

—

Persons encountering health services in other circumstances

226

2.44

8.72

1.4

1.3

—

85.39

—

Dialysis

10.06

8.65

1.1

1.4

—

Asthma

106

290

1.96

8.64

1.3

—

85.30

—

Selective serotonin reuptake inhibitors

126

359

1.85

8.60

1.3

86.80

79.49

mmol/24h

—

Parasetamol

251

2.01

8.56

1.4

1.3

96.78

72.96

mmol/24h

—

Asthma (mode)

104

292

1.96

8.49

1.3

—

85.30

—

Mouth breathing

237

2.36

8.34

1.3

1.2

—

88.36

—

Hypertensive Renal Disease

+∞

8.34

1.4

0.0

—

Pure hypercholesterolaemia

209

2.22

8.16

1.2

—

89.38

—

Other systemic involvement of connective tissue (FG)

112

3.02

8.14

1.1

1.2

—

91.09

—

Volume depletion

9.11

8.08

1.7

1.1

—

Hyperkalaemia

17.23

8.07

1.1

—

Other and unspecified effects of external causes

158

2.66

8.02

1.1

1.3

—

96.20

—

Other septicaemia

173

2.56

7.90

1.3

—

90.61

—

Covid-19 confirmed case

137

2.78

7.87

1.3

—

96.20

—

Migraine with aura

106

3.02

7.71

1.3

1.2

—

93.14

—

Hyperlipidaemia, other/unspecified

136

2.72

7.67

1.2

—

86.21

—

Asthma (diagnoses ohter than nonallergic)

105

499

1.80

7.38

1.3

—

78.89

—

Asthma, unspecified (mode), excluding more controls

247

2.10

7.14

1.3

—

88.25

—

Irritable bowel syndrome

145

2.63

7.10

1.3

1.2

—

95.90

—

Complications of procedures, not elsewhere classified

449

1.83

7.07

1.2

1.3

—

83.25

—

Asthma (only as main-diagnosis)

290

1.89

7.01

1.3

—

85.30

—

Asthma (only as main-diagnosis), excluding more controls

278

1.91

6.98

1.3

—

85.30

—

Asthma, unspecified (mode)

255

2.05

6.77

1.3

—

88.25

—

Retention of urine

115

2.65

6.63

1.2

1.3

—

81.79

—

Acute tubulo-interstitial nephritis

317

1.96

6.48

1.3

1.2

—

82.29

—

IgA nephropathy (IgA glomerulonephritis)

18.17

6.27

1.8

1.2

—

Epilepsy

131

2.59

6.23

1.2

1.3

—

91.86

—

Migraine without aura

2.99

6.21

1.3

—

90.85

—

Other systemic involvement of connective tissue

133

2.56

6.09

1.1

1.3

—

88.82

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

347

1.93

6.09

1.2

1.3

—

84.95

—

Complications of medical and surgical care

438

1.80

6.02

1.1

1.3

—

83.26

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

365

1.88

5.85

1.2

1.3

—

81.45

—

Implicit bacterial Sepsis

152

2.35

5.78

1.2

1.3

—

88.41

—

256

2.06

5.75

1.3

—

82.65

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

108

395

1.67

5.61

1.4

1.2

—

81.46

—

Disorders of adrenal gland, other and/or unspecified

+∞

5.23

1.0

0.0

—

Dermatitis and eczema

123

515

1.57

5.06

1.3

—

78.89

—

Other general symptoms and signs

9.93

4.99

1.1

2.0

—

Dermatitis

380

1.79

4.97

1.2

1.3

—

84.76

—

Other/unspecified dorsalgia

201

2.08

4.77

1.3

—

84.58

—

Other functional intestinal disorders

224

2.00

4.76

1.2

—

94.43

—

Allergic asthma (mode)

130

2.34

4.67

1.3

1.4

—

87.74

—

Allergic asthma (mode), excluding more controls

131

2.33

4.60

1.3

1.4

—

87.74

—

Symptoms and signs involving the digestive system and abdomen

112

355

1.58

4.58

1.3

94.14

76.68

mmol/24h

—

Hypertrophic cardiomyopathy

8.22

4.56

1.1

1.3

—

Asthma-related infections

341

1.79

4.55

1.3

—

85.49

—

Asthma, hospital admission 2, infections

341

1.79

4.55

1.3

—

85.49

—

Unspecified haematuria

170

2.07

4.48

1.5

1.3

—

79.26

—

STROKE

239

1.80

4.38

1.2

1.3

—

89.16

—

Diverticular disease of intestine

273

1.73

4.34

1.2

1.3

79.80

87.49

mmol/24h

—

Insulin medication

294

1.78

4.28

1.4

1.2

—

89.11

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

159

2.14

4.19

1.3

—

73.69

—

Asthma, hospital admissions , main diagnosis only

516

1.58

4.17

1.3

—

78.89

—

Finngen Rheumatological endpoints

109

403

1.54

4.16

1.3

85.63

76.92

mmol/24h

—

Contact with nonpowered hand tool

6.95

4.16

1.6

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

108

429

1.54

4.16

1.4

1.3

—

82.87

—

Acute upper respiratory infections of multiple and unspecified sites

390

1.61

4.10

1.3

—

79.68

—

Other dialysis

8.05

4.06

1.1

1.4

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.50

4.03

1.2

1.4

—

97.62

—

Viral and other specified intestinal infections

2.44

3.99

1.2

1.3

—

90.85

—

Other and unspecified dermatitis

311

1.77

3.95

1.3

—

86.85

—

Suicide or other Intentional self-harm

137

2.19

3.94

1.3

—

96.20

—

Obesity, other/unspecified

184

2.01

3.91

1.2

1.3

—

87.33

—

Suppurative and unspecified otitis media

199

1.92

3.89

1.5

1.3

—

83.43

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

119

456

1.49

3.89

1.3

71.16

81.65

mmol/24h

—

Nerve, nerve root and plexus disorders

114

479

1.50

3.89

1.2

1.3

85.58

78.15

mmol/24h

—

Other aneurysm

7.30

3.86

1.3

1.4

—

Asthma and allergy, excluding more controls

2.78

3.86

1.2

1.3

—

96.14

—

Poisoning by medicine

115

2.26

3.70

1.2

1.4

—

96.20

—

Asthma and allergy

2.70

3.66

1.2

1.3

—

96.14

—

Care involving use of rehabilitation procedures

404

1.62

3.61

1.2

1.3

—

83.26

—

Dronedarone medication

7.82

3.56

1.0

1.2

—

Insulin, intermediate and long-acting

309

1.71

3.51

1.4

1.3

—

91.13

—

Drug-induced adrenocortical insufficiency

10.08

3.50

1.2

1.3

—

Provisional assignment of new diseases of uncertain etiology

272

1.77

3.46

1.3

—

85.84

—

Codes for special purposes

272

1.77

3.46

1.3

—

85.84

—

Insulin, combination of fast acting with intermediate-acting or long-acting

340

1.65

3.45

1.4

1.2

—

89.26

—

Insulin, fast-acting

194

1.91

3.41

1.5

1.3

—

91.18

—

Insulin, fast-acting or short human

202

1.88

3.36

1.5

1.3

—

91.18

—

Noninfective enteritis and colitis

282

1.74

3.35

1.3

—

86.85

—

Combinations of oral blood glucose lowering drugs

127

2.13

3.34

1.3

1.2

—

90.67

—

Urticaria and erythema

218

1.84

3.29

1.2

1.3

—

87.33

—

Vasculitis limited to skin, not elsewhere classified

8.62

3.26

1.0

1.3

—

Any mental disorder

121

423

1.43

3.25

1.3

90.80

70.23

mmol/24h

—

Duodenal ulcer

3.58

3.19

1.2

—

Glaucoma-related operations

5.35

3.19

1.5

1.3

—

Carbimazole or st.post thyroidectomy, condition for graves disease

2.27

3.18

1.3

—

88.82

—

Type 1 diabetes

124

2.10

3.11

1.7

1.3

—

97.17

—

Type 1 diabetes, wide definition, subgroup 1

2.25

3.11

1.7

1.3

—

97.00

—

Other and unspecified iron deficiency

145

2.00

3.08

1.4

1.3

—

91.62

—

Psychiatric diseases

119

420

1.42

3.06

1.3

88.49

70.23

mmol/24h

—

Triptan medication for migraine, min. 3 purchases

318

1.59

3.06

1.3

79.40

75.10

mmol/24h

—

Benign neoplasm of other and unspecified sites

7.53

3.05

1.7

1.1

—

Calculus of lower urinary tract

5.02

3.05

1.6

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

181

1.88

3.03

1.3

—

96.20

—

Poisoning by drugs, medicaments and biological substances

134

2.02

2.94

1.1

1.4

—

96.20

—

Diseases of liver

185

1.84

2.86

1.4

1.3

—

87.33

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

385

1.48

2.85

1.3

84.99

77.23

mmol/24h

—

Triptan medication for migraine, single purchase ok

385

1.48

2.85

1.3

84.99

77.23

mmol/24h

—

Internal derangement of knee

229

1.74

2.83

1.3

1.2

—

103.33

—

Asthma-related pneumonia

157

1.91

2.82

1.3

—

87.31

—

Asthma-related pneumonia or sepsis

157

1.91

2.82

1.3

—

87.32

—

Asthma, hospital admissions 3, pneumonia

157

1.91

2.82

1.3

—

87.31

—

Gastroduodenal ulcer

103

2.13

2.78

1.2

1.3

—

96.11

—

Other cataract

171

1.77

2.77

1.3

—

88.41

—

Other noninfective gastroenteritis and colitis

110

2.09

2.77

1.3

—

89.82

—

Paraplegia, diplegia of upper limbs

8.38

2.75

1.4

1.2

—

Other and unspecified vasculitis limited to skin

8.37

2.75

1.0

1.2

—

Nontoxic goitre/thyroid nodule

152

1.91

2.74

1.2

—

85.82

—

Other diseases of spinal cord

6.03

2.70

1.3

1.4

—

Benign neoplasm of other and unspecified sites

6.02

2.70

1.7

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

234

1.71

2.65

1.5

1.3

—

85.66

—

Abnormal findings on examination of blood, without diagnosis

233

1.69

2.64

1.4

1.3

—

89.12

—

Type 1 diabetes, wide definition

106

2.08

2.61

1.7

1.3

—

97.00

—

Acute suppurative otitis media

144

1.88

2.61

1.7

1.3

—

89.27

—

Malignant neoplasm of kidney, except renal pelvis

3.61

2.57

1.1

1.2

—

Fungal Sepsis

7.17

2.55

1.4

—

Simple and mucopurulent chronic bronchitis

7.16

2.55

1.4

1.1

—

Specific development disorders of speech and language

4.22

2.39

1.1

1.5

—

Pollen allergy

109

2.00

2.39

1.1

1.4

—

99.48

—

Secondary polycythaemia

6.28

2.37

1.2

1.1

—

Other disorders starting during childhood or adolecense, excluding more controls

4.83

2.33

1.3

1.6

—

Urticaria

184

1.74

2.30

1.1

1.3

—

89.83

—

Normotensive glaucoma

3.22

2.30

1.1

1.3

—

Dentofacial anomalies [including malocclusion]

182

1.74

2.30

1.3

—

83.42

—

Cardiodefibrillation

169

1.77

2.30

1.3

1.2

—

82.23

—

Other and unspecified glaucoma

4.62

2.27

1.3

—

Other disorders starting during childhood or adolescence

4.59

2.25

1.3

1.6

—

Malignant neoplasm of urinary organs

3.11

2.22

1.1

1.2

—

Carrier of infectious disease

5.58

2.21

1.8

—

Benign neoplasm: Skin of lower limb, including hip

5.58

2.21

1.0

1.3

—

Other diseases of pericardium

5.57

2.21

1.2

—

Inflammatory diseases of female pelvic organs

329

1.47

2.21

1.3

—

75.83

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

5.56

2.21

1.2

1.8

—

Sub-endpoint used in defining T1D endpoints

147

1.81

2.21

1.7

1.3

—

94.13

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.02

2.15

1.1

1.3

—

89.82

—

Sequelae of external causes of morbidity and mortality

122

1.89

2.15

1.2

1.3

—

89.82

—

Fracture of neck

4.29

2.15

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

210

1.66

2.13

1.1

1.3

—

89.34

—

Oxycodone

154

1.76

2.10

1.3

—

79.64

—

Personality disorders, excluding more controls

145

1.79

2.09

1.2

1.3

—

79.93

—

Other and unspecified vascular occlusions

2.91

2.07

1.6

1.2

—

Specific development disorders of scholastic skills

4.95

2.05

1.2

2.3

—

Disorders of speech understanding and production

4.92

2.04

1.2

1.1

—

Use of selegiline

4.56

1.94

1.4

1.3

—

Glaucoma suspect

180

1.67

1.91

1.1

1.3

—

86.65

—

Disorders of choroid and retina

365

1.40

1.90

1.4

1.2

—

88.47

—

Other enthesopathies

165

1.70

1.90

1.1

1.2

—

73.47

—

Inflammatory bowel disease

181

1.66

1.87

1.3

—

91.86

—

Injuries to the neck

114

1.84

1.86

1.2

1.4

—

97.62

—

Inflammatory disease of uterus

2.09

1.86

1.3

—

99.48

—

Diseases of arteries, arterioles and capillaries

283

1.45

1.85

1.3

1.2

—

85.49

—

Other disorders of optic [2nd] nerve and visual pathways

3.54

1.83

1.2

1.6

—

Injury of other and unspecified intrathoracic organs

3.54

1.83

1.2

1.3

—

Osteoporosis with pathological fracture (FG)

3.54

1.83

1.2

—

Retinal vascular occlusion

2.50

1.83

1.5

1.3

—

Retinal vascular disorders

2.50

1.83

1.5

1.3

—

Presbycusis

2.49

1.81

1.1

1.3

—

Other benign neoplasms of skin

199

1.61

1.79

1.2

—

83.92

—

Sequelae of injuries, of poisoning and of other consequences of external causes

117

1.80

1.73

1.1

1.3

—

91.84

—

Chronic hepatitis, not elsewhere classified

3.86

1.71

1.2

1.3

—

Clear cell adenocarcinoma of kidney

3.85

1.71

1.0

1.3

—

Vascular disorders of the intestines

3.85

1.71

1.2

1.3

—

Dentinal caries

132

1.73

1.70

1.3

—

83.42

—

Embedded and impacted teeth

138

0.43

1.68

1.3

—

90.85

—

Other female pelvic inflammatory diseases

1.93

1.64

1.3

—

88.82

—

Voice disturbances

127

1.73

1.63

1.4

1.2

—

87.31

—

Stroke, including SAH

270

1.43

1.63

1.3

—

85.49

—

Medical treatment for female infertility

148

0.40

1.63

1.3

1.4

—

86.02

—

Extrapyramidal and movement disorders

181

1.60

1.62

1.4

1.2

—

84.96

—

Other retinal disorders

281

1.43

1.61

1.4

1.3

—

87.51

—

Osteonecrosis

3.58

1.61

1.0

1.4

—

Use of antiglaucoma preparations and miotics

3.00

1.58

1.2

1.3

—

Ulcerative colitis

121

1.74

1.57

1.2

1.3

—

94.13

—

Sleep disorders

114

1.76

1.56

1.5

1.3

—

96.20

—

Unspecified kidney failure

2.86

1.50

1.5

1.2

—

Other benign neoplasms of skin

205

1.53

1.50

1.2

—

88.75

—

Glucagon-like peptide-1 (GLP-1) analogues

238

1.45

1.49

1.3

1.2

—

86.21

—

Sulfasalazine

163

1.60

1.45

1.5

1.3

—

88.87

—

Functional dyspepsia

132

1.67

1.45

1.3

1.2

—

91.45

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

189

0.54

1.45

1.1

1.2

—

90.29

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

341

1.39

1.44

1.2

—

86.91

—

Behavioural syndromes associated with physiological disturbances and physical factors

195

1.54

1.44

1.5

1.3

—

89.27

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

3.13

1.44

1.0

1.3

—

Childhood asthma (age<16), excluding more controls

1.95

1.44

1.4

—

96.14

—

Fissure and fistula of anal and rectal regions

125

1.68

1.43

1.4

1.3

—

95.49

—

Salpingitis and oophoritis

1.79

1.42

1.5

1.2

—

87.02

—

Stroke, excluding SAH

248

1.41

1.42

1.2

1.3

—

85.49

—

Disorders of skin appendages

311

1.41

1.42

1.4

1.3

—

84.92

—

Intestinal stricture

141

1.63

1.41

1.2

1.3

—

89.82

—

Acute bronchiolitis

2.70

1.40

1.2

—

Glaucoma, exfoliation

2.42

1.39

1.0

1.2

—

Childhood asthma (age<16)

1.92

1.38

1.4

—

96.14

—

Polymyalgia rheumatica

2.20

1.36

1.2

—

Keratitis

198

1.52

1.36

1.2

1.3

—

89.33

—

Carcinoma in situ of skin

2.61

1.36

1.0

1.2

—

Impacted teeth

116

0.40

1.36

1.2

1.3

—

90.85

—

Acute pharyngitis

1.88

1.36

1.5

1.3

—

98.25

—

Personality disorders

167

1.56

1.33

1.2

1.3

—

93.41

—

Symptoms and signs involving speech and voice

167

1.56

1.33

1.4

1.2

—

87.32

—

Disorders of adult personality and behaviour

184

1.52

1.31

1.2

1.3

—

87.70

—

Idiopathic gout

2.50

1.30

1.3

1.4

—

Fracture of skull and facial bones

1.72

1.26

1.1

1.4

—

91.84

—

Specific personality disorders

138

1.60

1.25

1.2

1.3

—

96.20

—

Deviated nasal septum

170

1.53

1.25

1.0

1.3

—

92.65

—

Injuries to the knee and lower leg

112

523

1.23

1.24

1.2

1.3

—

78.89

—

Pulmonary heart disease

123

1.63

1.23

1.3

—

91.19

—

Pulmonary embolism

123

1.63

1.23

1.3

—

91.19

—

Injury of muscle and tendon at lower leg level

1.91

1.22

1.1

1.3

—

91.84

—

Diseases of middle ear and mastoid

332

1.33

1.22

1.5

1.3

—

83.89

—

Degenerative macular diseases

2.16

1.21

1.1

1.2

—

Sequelae with surgical and medical care as external cause

1.77

1.16

1.3

—

89.82

—

Olecranon bursitis

2.50

1.15

1.0

1.3

—

Venous thromboembolism

293

1.36

1.10

1.3

1.2

—

84.75

—

Long labour

143

0.55

1.09

1.6

1.3

—

99.34

—

Alcohol dependence

144

1.53

1.08

1.1

1.3

—

95.49

—

Squamous cell neoplasms and carcinomas of the skin

2.19

1.08

1.1

1.2

—

Parodontitis and operation codes

496

0.77

1.05

1.3

—

82.87

—

Maternal care for other conditions predominantly related to pregnancy

136

1.52

1.02

1.3

—

90.16

—

Parodontitis or operation codes

501

0.78

1.02

1.3

—

82.87

—

Mycoses

130

1.54

1.02

1.4

1.3

—

89.82

—

Parodontitis

501

0.78

1.02

1.3

—

82.87

—

Chronic periodontitis, including avohilmo

502

0.78

1.01

1.3

—

82.87

—

Atherosclerosis, excluding cerebral and coronary sclerosis

143

1.45

1.00

1.2

1.3

—

82.23

—

Delirium, not induced by alcohol and other psychoactive substances

2.00

0.99

1.0

1.3

—

Parodontitis or/and operation codes

309

0.75

0.98

1.3

—

66.02

—

ILD, hospital admissions 3, with pneumonia sepsis

2.18

0.98

1.8

1.2

—

Retinal detachments and breaks

181

1.44

0.97

1.6

1.3

—

85.49

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

216

1.35

0.96

1.2

1.3

—

87.85

—

Coronary angioplasty

144

0.59

0.96

1.2

—

82.23

—

Dislocation, sprain and strain of joints and ligaments of knee

403

1.27

0.94

1.3

—

82.57

—

Non-allergic asthma (mode), excluding more controls

1.62

0.94

1.2

1.3

—

92.92

—

Pulmonary heart disease, diseases of pulmonary circulation

142

1.48

0.91

1.2

1.3

—

88.85

—

Carcinoma in situ of skin

2.15

0.91

1.0

1.2

—

Familial hypercholesterolemia, with ischemic heart disease

2.14

0.91

1.2

—

Non-allergic asthma (mode)

1.60

0.90

1.2

—

91.90

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.60

0.90

1.4

1.3

—

99.48

—

Benign neoplasm: Colon, unspecified

102

1.57

0.90

1.3

1.2

—

89.82

—

Other and unspecified tonsillitis

185

1.38

0.89

1.4

1.3

—

88.48

—

Atopic dermatitis, strict definition

182

1.40

0.87

1.3

—

89.27

—

Endometriosis of rectovaginal septum and vagina

2.00

0.87

1.5

1.4

—

Colonic or urogenital fistula

144

1.46

0.87

1.4

1.3

—

87.63

—

Atopic dermatitis, strict definition with reimbursement

190

1.38

0.83

1.4

1.3

—

89.27

—

Iridocyclitis

105

1.52

0.81

1.2

1.3

—

89.82

—

Car occupant injured in other and unspecified transport accidents

1.55

0.81

1.2

1.3

—

96.20

—

Bipolar affective disorders

1.55

0.81

1.1

1.3

—

102.56

—

Nasal polyp

1.61

0.81

1.5

1.3

—

98.57

—

Disorders of sclera, cornea, iris and ciliary body

355

1.27

0.80

1.2

1.3

—

88.40

—

Entropion and trichiasis of eyelid

0.00

0.79

0.0

1.3

—

IBD patients in KELA-register

114

1.49

0.79

1.3

1.4

—

97.62

—

Benign neoplasm: Transverse colon

1.77

0.76

1.0

1.2

—

Psoriasis

157

1.40

0.76

1.5

1.3

—

90.29

—

Malignant neoplasm of digestive organs

171

0.63

0.76

1.1

1.2

—

89.12

—

Other fall from one level to another

107

1.50

0.75

1.5

1.3

—

94.13

—

Peripheral arterial reconstruction

1.70

0.75

1.3

1.2

—

Postmenopausal osteoporosis with pathological fracture

2.09

0.74

1.0

1.2

—

Bacterial pneumonia, not elsewhere classified

184

0.67

0.73

1.1

1.3

—

89.36

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

1.75

0.71

1.1

1.2

—

Other obstetric conditions, not elsewhere classified

154

1.31

0.68

1.4

1.3

—

81.23

—

Primary_lymphoid and hematopoietic malignant neoplasms

117

0.60

0.67

1.4

1.2

—

92.55

—

DVT of lower extremities and pulmonary embolism

213

1.31

0.67

1.3

—

85.49

—

Benign neoplasm: Colon, unspecified

110

1.45

0.66

1.3

1.2

—

91.45

—

Other and unspecified disorders of vitreous body

213

1.31

0.66

1.2

1.3

—

87.93

—

Rheumatoid arthritis, including avohilmo

215

1.30

0.64

1.3

1.2

—

84.09

—

Atopic dermatitis

328

1.22

0.64

1.3

—

80.23

—

Motorcycle rider injured in other and unspecified transport accidents

1.73

0.64

1.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

191

1.26

0.60

1.2

—

88.75

—

Inflammatory bowel disease, strict (require KELA)

122

1.39

0.60

1.3

1.4

—

97.62

—

Open wound of head

296

1.23

0.57

1.1

1.3

—

92.94

—

Disorders of vitreous body

268

1.24

0.56

1.2

1.3

—

86.91

—

Coxarthrosis, primary, with hip surgery

218

1.26

0.54

1.1

1.2

—

88.85

—

Bacterial pneumonia (organism specified)

217

0.76

0.52

1.2

1.3

—

89.36

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

150

1.26

0.51

1.4

1.3

—

81.23

—

Other gastritis (incl. Duodenitis)

101

1.39

0.49

1.7

1.3

—

91.45

—

Chronic gastritis

127

1.34

0.49

1.5

1.3

—

88.01

—

Seropositive rheumatoid arthritis

118

1.35

0.49

1.4

1.2

—

91.09

—

Use of levodopa decarboxylase inhibitor

1.56

0.49

1.4

1.2

—

Bacterial pneumoniae

198

0.76

0.48

1.2

1.3

—

89.36

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

154

1.30

0.48

1.4

—

91.19

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.37

0.48

1.1

1.2

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.38

0.45

1.3

1.4

—

97.62

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

127

0.69

0.43

1.1

1.3

—

92.87

—

L01XE Protein kinase inhibitors

0.00

0.41

0.0

1.3

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.41

0.0

1.2

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.41

0.0

1.1

—

Follicular lymphoma

0.00

0.41

0.0

1.3

—

Disorders of vitreous body and globe

280

1.18

0.39

1.2

1.3

—

86.91

—

Primary_lymphoid and hematopoietic malignant neoplasms

103

0.68

0.39

1.4

1.3

—

89.82

—

Other and unspecified urticaria

1.34

0.39

1.1

1.3

—

97.62

—

Benign neoplasm: Caecum

1.43

0.39

1.0

1.2

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

0.39

0.0

1.3

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.38

0.38

1.3

1.4

—

97.62

—

Myocardial infarction, strict

189

0.81

0.38

1.4

1.2

—

77.65

—

Parkinson's disease, strict definition, excluding more controls

1.44

0.35

1.2

—

ILD, hospital admissions 1, main diag only

1.43

0.35

1.8

1.3

—

Complications predominantly related to the puerperium

168

0.77

0.35

1.4

1.2

—

89.60

—

Ulcerative colitis (strict definition, require KELA)

1.34

0.34

1.3

1.4

—

97.62

—

Fall on and from stairs and steps

118

1.27

0.33

1.5

1.3

—

89.82

—

Degeneration of macula and posterior pole

180

1.19

0.33

1.2

—

76.40

—

Pre-eclampsia or eclampsia

138

1.23

0.30

1.2

—

89.60

—

Fracture of lower leg, including ankle

343

1.13

0.29

1.2

1.3

—

88.40

—

Organic, including symptomatic, mental disorders

180

0.84

0.28

1.4

1.2

—

74.33

—

Emotionally unstable personality disorder

1.23

0.27

1.0

1.3

—

99.48

—

Ischaemic Stroke, excluding all haemorrhages

240

1.13

0.27

1.2

1.3

—

85.49

—

Other disorders of bone

104

1.25

0.26

1.0

1.3

—

91.84

—

Tooth eruption problems

0.70

0.26

1.2

1.4

—

90.85

—

Use of memantine

0.66

0.26

1.6

1.2

—

Use of other anti-dementia drugs

0.66

0.26

1.6

1.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

132

1.21

0.25

1.4

1.3

—

84.96

—

Other/unspecified seropositive rheumatoid arthritis

132

1.21

0.25

1.4

1.3

—

84.96

—

Injuries to the hip and thigh

234

0.86

0.25

1.1

1.3

—

87.33

—

Obstructed labour due to malposition and malpresentation of fetus

150

0.82

0.25

1.2

1.3

—

85.12

—

Speech therapy

137

0.80

0.24

1.0

1.3

—

87.31

—

Myocardial infarction, without ST-elevation

166

0.83

0.24

1.3

—

79.26

—

Striking against or struck by other objects

180

1.17

0.23

1.3

1.4

—

93.99

—

Peripheral artery disease

160

1.16

0.23

1.2

—

82.23

—

Benign neoplasm: Caecum

1.25

0.22

1.0

1.3

—

Basal cell carcinoma, including avohilmo

232

1.12

0.22

1.2

1.3

—

85.49

—

Status post-ami

0.00

0.21

0.0

1.1

—

Oral leukoplakia, including avohilmo

0.00

0.21

0.0

1.3

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.3

—

Hodgkin lymphoma, hilmo

0.00

0.21

0.0

1.2

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.21

0.0

1.4

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.3

—

Renal cell carcinoma of kidney

0.00

0.21

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

0.21

0.0

1.3

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Non-Hodgkin lymphoma, all

0.00

0.21

0.0

1.2

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.21

0.0

1.3

—

Other congenital malformations of the digestive system

0.00

0.21

0.0

1.3

—

Alzheimer’s disease (Early onset)

0.00

0.21

0.0

1.4

—

Seropositive rheumatoid arthritis, wide

135

1.19

0.21

1.4

1.2

—

84.96

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Acute alcohol intoxication ICD-9

0.00

0.21

0.0

1.3

—

Other disorders of male genital organs

0.00

0.21

0.0

1.3

—

Acute alcohol intoxication, ICD10

1.22

0.21

1.5

1.3

—

91.84

—

Pedal cyclist injured in collision with motor vehicle

0.00

0.21

0.0

1.6

—

Other vitreous opacities

0.00

0.21

0.0

1.3

—

Follicular lymphoma, hilmo

0.00

0.21

0.0

1.3

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

0.21

0.0

1.3

—

Use of galantamine

0.00

0.21

0.0

1.1

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.2

—

Parkinson's disease, strict definition

1.25

0.20

1.2

—

Dementia in Alzheimer disease

1.19

0.19

1.8

1.2

—

Persons encountering health services in circumstances related to reproduction

304

0.91

0.19

1.4

1.3

96.13

82.51

mmol/24h

—

Superficial injury of lower leg

118

1.19

0.19

1.1

1.3

—

90.20

—

Effects of foreign body entering through natural orifice

118

1.19

0.19

1.1

1.4

—

92.87

—

Basal cell carcinoma

230

1.11

0.18

1.2

1.3

—

85.49

—

Haemorrhage in early pregnancy

189

1.14

0.18

1.5

1.3

—

83.78

—

Other medical care

212

0.87

0.18

1.5

1.2

—

87.51

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

200

0.88

0.18

1.3

1.2

—

90.29

—

Emergency coronary revascularization (for ACS)

209

0.89

0.18

1.3

1.2

—

82.23

—

Transient ischemic attack

240

1.10

0.18

1.1

1.3

—

85.49

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.13

0.17

1.6

1.3

—

99.48

—

Myocardial infarction

200

0.90

0.17

1.4

1.2

—

85.49

—

Other viral diseases

176

1.13

0.16

1.2

1.3

—

87.70

—

Pre-eclampsia

130

1.15

0.15

1.2

—

89.60

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

188

1.10

0.15

1.2

—

88.75

—

Alzheimer disease

0.81

0.14

1.6

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

106

0.85

0.13

1.3

—

99.48

—

Abnormal findings on diagnostic imaging of lung

244

1.08

0.10

1.2

—

85.49

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

186

1.08

0.10

1.2

—

88.75

—

Covid-19 suspected case

114

0.88

0.09

1.1

1.2

—

96.20

—

Parkinson's disease

1.11

0.09

1.2

—

1.09

0.08

1.3

—

99.48

—

Other strabismus

113

0.88

0.08

1.0

1.3

—

94.32

—

Parkinson's disease, including avohilmo

1.05

0.08

1.2

—

Eating disorders

1.03

0.08

1.8

1.3

—

99.48

—

Nonsuppurative otitis media

119

1.09

0.06

1.4

1.3

—

90.85

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

111

0.90

0.06

1.1

1.2

—

92.55

—

Unspecified mental disorder

268

1.04

0.04

1.3

—

90.94

—

Infections with a predominantly sexual mode of transmission

200

0.95

0.04

1.2

1.3

—

83.43

—

Strabismus

141

1.06

0.03

1.1

1.3

—

96.20

—

Injury of muscle and tendon at shoulder and upper arm level

199

0.95

0.03

1.1

1.3

—

88.85

—

Fitting and adjustment of other devices

161

1.04

0.01

1.2

—

86.59

—

Kela-code for severe mental illness

238

1.01

0.00

1.3

—

90.94

—

Acute alcohol intoxication

135

1.04

0.00

1.4

1.3

—

95.49

—

Coronary revascularization (ANGIO or CABG)

177

0.99

0.00

1.3

1.2

—

80.33

—

Abnormal serum enzyme levels

141

0.98

0.00

1.3

—

81.79

—

Other disorders of teeth and supporting structures

128

1.02

0.00

1.2

1.3

—

89.37

—

Special screening examination for infectious and parasitic diseases

128

0.99

0.00

1.1

1.4

—

79.31

—

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Other specified and unspecified retinal disorders

0.00

0.0

1.3

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.0

1.3

—

Adenocarcinoma of pancreas

0.00

0.0

1.3

—

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

Melanocytic naevi of upper limb, including shoulder

0.00

0.0

1.4

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.00

0.0

1.4

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

Melanocytic naevi of eyelid, including canthus

0.00

0.0

1.2

—

Need for immunization against other single viral diseases

0.00

0.0

1.3

—

Vascular diseases of the intestine

0.00

0.0

1.3

—

Encephalopathy

0.00

0.0

1.0

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

0.0

1.3

—

Monoplegia

0.00

0.0

1.2

—

Dermatopolymyositis

0.00

0.0

1.2

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

0.0

1.4

—

Pulmonary eosinophilia, not elsewhere classified

0.00

0.0

1.4

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Other diseases of lip and oral mucosa

0.91

0.00

1.4

1.3

—

91.90

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.0

1.5

—

Malignant neoplasm of oropharynx

0.00

0.0

1.3

—

Multiple myeloma

0.00

0.0

1.3

—

Pyogenic granuloma

0.00

0.0

1.2

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Inguinal hernia, unilateral

0.00

0.0

1.5

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

0.00

0.0

1.3

—

Benign neoplasm: Vagina

0.00

0.0

1.4

—

Benign neoplasm: other/unspecified salivary gland

0.00

0.0

1.3

—

Superficial injury of neck

0.00

0.0

1.2

—

Disorders of globe

0.00

0.0

1.3

—

Myeloid leukaemia

0.00

0.0

1.3

—

Benign neoplasm: Brain, supratentorial

0.00

0.0

1.2

—

Small cell lung cancer

0.00

0.0

1.4

—

Inguinal of femoral hernia, unilateral

0.00

0.0

1.5

—

Wet age-related macular degeneration

0.98

0.00

1.2

—

Alzheimer disease, excluding more controls

0.99

0.00

1.7

1.2

—

Benign neoplasm: Vagina

0.00

0.0

1.3

—

Benign neoplasm: other/unspecified salivary gland

0.00

0.0

1.4

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.0

1.4

—

Keratoconus

0.00

0.0

1.3

—

Viral conjunctivitis

0.00

0.0

1.3

—

Benign neoplasm: Other and unspecified parts of small intestine

0.00

0.0

1.2

—

Benign neoplasm: Brain, supratentorial

0.00

0.0

1.3

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.00

0.0

1.3

—

Melanocytic naevi of upper limb, including shoulder

0.00

0.0

1.3

—

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Amputation of ankle bones

0.00

0.0

1.3

—

Shoulder region

0.00

0.0

1.2

—

Portal vein thrombosis

0.00

0.0

1.2

—

Other disorders of prostate

0.00

0.0

1.2

—

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Donors of organs and tissues

0.00

0.0

1.5

—

Ankle and foot

0.00

0.0

1.4

—

Alcohol abuse counselling and surveillance

0.00

0.0

1.4

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.0

1.4

—

LSIL lesion of the cervix uteri, vagina or vulva

1.01

0.00

1.1

1.3

—

99.48

—

Accidental poisoning by and exposure to alcohol

0.00

0.0

1.0

—

Evidence of alcohol involvement determined by blood alcohol level

0.00

0.0

1.2

—

Contact with lifting and transmission devices, not elsewhere classified

0.00

0.0

1.3

—

HSIL lesion of the vagina

0.00

0.0

1.2

—

Helminthiases

0.00

0.0

1.6

—

Benign neoplasm: Appendix

0.00

0.0

1.3

—

HSIL lesion of the vulva

0.00

0.0

1.3

—

Malignant neoplasm of small intestine

0.00

0.0

1.3

—

Malignant neoplasm of tonsil

0.00

0.0

1.3

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.00

0.0

1.4

—

Use of donepezil

0.84

0.00

1.4

1.2

—

Colorectal neuroendocrine tumor and carcinoma

0.00

0.0

1.4

—

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

Iridocyclitis in diseases classified elsewhere

0.00

0.0

1.1

—

Abnormal findings on diagnostic imaging of breast

0.00

0.0

1.3

—

Femoral hernia, unilateral

0.00

0.0

1.5

—

Congenital deformities of hip

0.00

0.0

1.4

—

Communicating hydrocephalus

0.00

0.0

1.1

—

Other interventions on the root canals of the tooth

0.00

0.0

1.3

—

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

0.0

1.4

—

Discitis, unspecified

0.00

0.0

1.0

—

Retinoschisis and retinal cysts

0.00

0.0

1.3

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Myeloid leukaemia

0.00

0.0

1.4

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

0.0

1.0

—

Hodgkin lymphoma

0.00

0.0

1.3

—

Other melanin hyperpigmentation

0.00

0.0

1.3

—

Unspecified nephritic syndrome

0.00

0.0

1.3

—

Synovial hypertrophy, not elsewhere classified

0.00

0.0

1.3

—

Small cell lung cancer, helper endpoint

0.00

0.0

1.4

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

0.00

0.0

1.3

—

Alcoholic gastritis

0.00

0.0

1.4

—

Oral leukoplakia

0.00

0.0

1.2

—

Oesophageal obstruction

0.00

0.0

1.3

—

Acute posthaemorrhagic anaemia

0.00

0.0

1.3

—

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

Overjet

0.00

0.0

1.3

—

Anomalies of pupillary function

0.00

0.0

1.2

—

Benign neoplasm: Other and unspecified parts of small intestine

0.00

0.0

1.2

—

Anaemia in chronic diseases classified elsewhere

0.00

0.0

1.3

—

Other bursitis of knee

0.00

0.0

1.2

—

Non-small cell lung cancer, squamous

0.00

-0.00

0.0

1.3

—

Guillain-Barre syndrome

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of larynx

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

1.3

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

-0.00

0.0

1.3

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Potassium [Moles/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS